Published in: 2nd International Personalized Medical Congress
COI code: IPMCMED02_131
Paper Language: English
How to Download This Paper
For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.
Authors Personalized Medicine in Gastroenterology DisordersMohammad Reza Zali - Professor of Gastroenterology, Research Institute for Gastroenterology and Liver, Shahid Beheshti University of Medical Sciences
Abstract:Medicine is now developing as personalized solutions for a particular patient’s needs, and there is a cumulative attention to personalized medicine. Personalized medicine is an extensive field of healthcare subjects which is informed by each person s unique clinical, genetic, genomic, and environmental information. Considerable progresses have taken place in biomedical science to make personalized medicine a feasible option. The translation of human genome information to clinical medicine needs answering three following questions: Which molecular factors are involved in the pathogenesis of a particular disease Which individuals or patients will develop a particular disease How a therapeutic regimen is developed that can be personalized to an individual with a unique biology In gastroenterology, personalized medicine is mostly applied for management inflammatory bowel diseases, gastrointestinal malignancies, H. pylori associated diseases, and many other diseases. Study of microbioma structures in different people is an attractive field in personalized medicine. Pathogenesis and manifestation of gastroenterology and liver diseases are a direct result of the interaction of the human genome and the bacterial genome. In this regards, the characteristics of the host s intestinal microflora is tremendously significant when beginning treatment of gastroenterology diseases because composition of gut microflora varies between different individuals. Applications of personalized medicine for the gastroenterology disorders are including: employment of novel therapeutic approaches, optimization of therapy, study of drug toxicity, development of efficient biomarkers for early detection of disease, identification of markers of response to therapy and study of virulency.
COI code: IPMCMED02_131
how to cite to this paper:If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Zali, Mohammad Reza, 2017, Personalized Medicine in Gastroenterology Disorders, 2nd International Personalized Medical Congress, تهران, دانشگاه علوم پزشكي بقيه الله(عج), https://www.civilica.com/Paper-IPMCMED02-IPMCMED02_131.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Zali, Mohammad Reza, 2017)
Second and more: (Zali, 2017)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)
The University/Research Center Information:
Type: state university
Paper No.: 16800
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.
Research Info Management
Export Citation info of this paper to research management softwares
New Related Papers
The Above articles are recently indexed in the related subjects
Iran Scientific Advertisment Netword
Share this paper
WHAT IS COI?
COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.